These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 1414498)

  • 1. Responsiveness to 1,25-dihydroxyvitamin D3 is reduced in lymphocytes from osteoporotic women.
    Koren R; Ravid A; Liberman UA; Narinsky R; Maron L; Weisman M; Samuel R
    J Bone Miner Res; 1992 Sep; 7(9):1057-61. PubMed ID: 1414498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective binding and function of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D.
    Koren R; Ravid A; Liberman UA; Hochberg Z; Weisman Y; Novogrodsky A
    J Clin Invest; 1985 Nov; 76(5):2012-5. PubMed ID: 2997300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro.
    Lemire JM; Adams JS; Kermani-Arab V; Bakke AC; Sakai R; Jordan SC
    J Immunol; 1985 May; 134(5):3032-5. PubMed ID: 3156926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D affects proliferation of a murine T helper cell clone.
    Lacey DL; Axelrod J; Chappel JC; Kahn AJ; Teitelbaum SL
    J Immunol; 1987 Mar; 138(6):1680-6. PubMed ID: 3029220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation.
    Bhalla AK; Amento EP; Serog B; Glimcher LH
    J Immunol; 1984 Oct; 133(4):1748-54. PubMed ID: 6206136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.
    Koga M; Eisman JA; Sutherland RL
    Cancer Res; 1988 May; 48(10):2734-9. PubMed ID: 2834048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum ionized calcium, as well as phosphorus and parathyroid hormone, is associated with the plasma 1,25-dihydroxyvitamin D3 concentration in normal postmenopausal women.
    Dawson-Hughes B; Harris S; Dallal GE
    J Bone Miner Res; 1991 May; 6(5):461-8. PubMed ID: 2068951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect by 1,25-dihydroxyvitamin D3 on concanavalin A-stimulated proliferation of rat thymic lymphocytes.
    Kojima A; Hato F; Kinoshita Y; Nishizawa Y; Morii H
    Cell Mol Biol (Noisy-le-grand); 1992 Dec; 38(8):867-75. PubMed ID: 1477603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha,25-Dihydroxyvitamin D3 modulates CD38 expression on human lymphocytes.
    Stoeckler JD; Stoeckler HA; Kouttab N; Maizel AL
    J Immunol; 1996 Dec; 157(11):4908-17. PubMed ID: 8943395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1 alpha,25-dihydroxyvitamin D3 inhibits pokeweed mitogen-stimulated human B-cell activation: an analysis using serum-free culture conditions.
    Shiozawa K; Shiozawa S; Shimizu S; Fujita T
    Immunology; 1985 Sep; 56(1):161-7. PubMed ID: 3876273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies.
    Sterck JG; Klein-Nulend J; Burger EH; Lips P
    J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic effect of 1,25-dihydroxyvitamin D3 on primary mouse epidermal keratinocyte proliferation.
    Bollag WB; Ducote J; Harmon CS
    J Cell Physiol; 1995 May; 163(2):248-56. PubMed ID: 7706369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone cell responsiveness to transforming growth factor beta, parathyroid hormone, and prostaglandin E2 in normal and postmenopausal osteoporotic women.
    Lomri A; Marie PJ
    J Bone Miner Res; 1990 Nov; 5(11):1149-55. PubMed ID: 2176773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25-dihydroxyvitamin D3 and agents that increase intracellular adenosine 3',5'-monophosphate synergistically inhibit the mitogenic stimulation of human lymphocytes.
    Ravid A; Koren R; Narinsky R; Rotem C; Novogrodsky A; Liberman A
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1687-92. PubMed ID: 1693374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic inhibitory effect of cyclosporin A and vitamin D derivatives on T-lymphocyte proliferation in active ulcerative colitis.
    Stio M; Treves C; Celli A; Tarantino O; d'Albasio G; Bonanomi AG
    Am J Gastroenterol; 2002 Mar; 97(3):679-89. PubMed ID: 11922564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells.
    Yamamoto T; Ozono K; Shima M; Yamaoka K; Okada S
    Exp Cell Res; 1998 Oct; 244(1):71-6. PubMed ID: 9770350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion.
    Brown AJ; Ritter C; Slatopolsky E; Muralidharan KR; Okamura WH; Reddy GS
    J Cell Biochem; 1999 Apr; 73(1):106-13. PubMed ID: 10088729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiproliferative effect of calcitriol on human peripheral blood mononuclear cells.
    Manolagas SC; Provvedini DM; Murray EJ; Tsoukas CD; Deftos LJ
    J Clin Endocrinol Metab; 1986 Aug; 63(2):394-400. PubMed ID: 3013918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25-Dihydroxyvitamin D3 acts directly on human lymphocytes and interferes with the cellular response to interleukin-2.
    Koren R; Liberman UA; Maron L; Novogrodsky A; Ravid A
    Immunopharmacology; 1989; 18(3):187-94. PubMed ID: 2606649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.